Viracta trades on the NASDAQ Global Select Market under the symbol VIRX. The company went public through a reverse
merger that was completed on February 24, 2021.
2533 S. Coast Hwy 101, Suite 210, Cardiff, CA 92007
The company’s fiscal year ends on December 31st.
Viracta does not expect to declare or pay any cash or other dividends on our common stock.
Viracta does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed via the SEC Filings section on this page
or directly from the SEC at www.sec.gov.
6201 15th Ave
Brooklyn, NY 11219
AST Shareholder Services Call Center
Toll Free: 800.937.5449
Local & International: 718-921-8124
Hours: 8 a.m. – 8 p.m. ET Monday-Friday